Evaluating the National Institutes of Health's Sex as a Biological Variable Policy: Conflicting Accounts from the Front Lines of Animal Research
- PMID: 33211575
- PMCID: PMC7957378
- DOI: 10.1089/jwh.2020.8674
Evaluating the National Institutes of Health's Sex as a Biological Variable Policy: Conflicting Accounts from the Front Lines of Animal Research
Abstract
Background: Since the National Institutes of Health (NIH) Revitalization Act of 1993, focus on the equitable inclusion of women in clinical research has been ongoing. NIH's 2015 sex as a biological variable (SABV) policy aims to transform research design, analysis, and reporting in the preclinical sphere by including male and female organisms in vertebrate animal research as well as human studies. However, questions remain regarding how researchers and members of research oversight committees perceive the value and need of the SABV policy. Materials and Methods: Based on 62 interviews with animal researchers and oversight personnel, we analyze what the animal research community knows about the policy and sees as the benefits and challenges of implementation. Results: We found that the 62 interviewees disagreed about the need for the policy, with some being supportive and others questioning whether the policy is based on science or is politically motivated. There were also tensions in how interviewees conceptualized the challenges to and resources needed for implementing the SABV policy. For instance, while some thought implementation would require a significant increase in numbers of animals used for each study, others explicitly rejected this claim. Conclusions: We conclude by discussing the practical and social implications of our findings about the views of members of the animal research community regarding the SABV policy.
Keywords: National Institutes of Health; animal researchers; policy; preclinical research; sex as a biological variable; women's health.
Conflict of interest statement
No competing financial interests exist.
Similar articles
-
Biomedical Researchers' Perceptions of the NIH's Sex as a Biological Variable Policy for Animal Research: Results from a U.S. National Survey.J Womens Health (Larchmt). 2021 Oct;30(10):1395-1405. doi: 10.1089/jwh.2020.8997. Epub 2021 Apr 8. J Womens Health (Larchmt). 2021. PMID: 33834877 Free PMC article.
-
Sex as a Biological Variable: A 5-Year Progress Report and Call to Action.J Womens Health (Larchmt). 2020 Jun;29(6):858-864. doi: 10.1089/jwh.2019.8247. Epub 2020 Jan 22. J Womens Health (Larchmt). 2020. PMID: 31971851 Free PMC article.
-
Sex and the Lab: An Alcohol-Focused Commentary on the NIH Initiative to Balance Sex in Cell and Animal Studies.Alcohol Clin Exp Res. 2016 Jun;40(6):1182-91. doi: 10.1111/acer.13072. Epub 2016 May 7. Alcohol Clin Exp Res. 2016. PMID: 27154003 Free PMC article. Review.
-
Applying the new SABV (sex as a biological variable) policy to research and clinical care.Physiol Behav. 2018 Apr 1;187:2-5. doi: 10.1016/j.physbeh.2017.08.012. Epub 2017 Aug 17. Physiol Behav. 2018. PMID: 28823546
-
Sex as a biological variable: a contemporary perspective.Am Heart J. 2025 Sep;287:10-15. doi: 10.1016/j.ahj.2025.03.012. Epub 2025 Mar 28. Am Heart J. 2025. PMID: 40158709 Review.
Cited by
-
Building a healthy mouse model ecosystem to interrogate cancer biology.Dis Model Mech. 2022 Sep 1;15(9):dmm049795. doi: 10.1242/dmm.049795. Epub 2022 Sep 13. Dis Model Mech. 2022. PMID: 36098988 Free PMC article.
-
Constructing the cure: engineering the next wave of antibody and cellular immune therapies.J Immunother Cancer. 2025 Aug 25;13(8):e011761. doi: 10.1136/jitc-2025-011761. J Immunother Cancer. 2025. PMID: 40854817 Free PMC article. Review.
-
Exclusion of Women from Phase I Trials: Perspectives from Investigators and Research Oversight Officials.Ethics Hum Res. 2023 Nov-Dec;45(6):19-30. doi: 10.1002/eahr.500170. Ethics Hum Res. 2023. PMID: 37988277 Free PMC article. Clinical Trial.
-
Sex Chromosomes and Sex Hormones: Dissecting the Forces That Differentiate Female and Male Hearts.Circulation. 2025 Feb 18;151(7):474-489. doi: 10.1161/CIRCULATIONAHA.124.069493. Epub 2025 Feb 17. Circulation. 2025. PMID: 39960989 Review.
-
The fate of surplus laboratory animals: Minimizing the production of surplus animals has the greatest potential to reduce the number of laboratory animals: Minimizing the production of surplus animals has greatest potential to reduce the number of laboratory animals.EMBO Rep. 2023 Mar 6;24(3):e56551. doi: 10.15252/embr.202256551. Epub 2023 Jan 30. EMBO Rep. 2023. PMID: 36715165 Free PMC article.
References
-
- National Institutes of Health. Consideration of sex as a biological variable in NIH-funded Research, 2015. Available at: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-102.html Accessed September17, 2020
-
- Roth D. Gender bias in clinical drug trials. Wisconsin J Law Gend Soc 2018;33:83–105
-
- Pinnow E, Sharma P, Parekh A, Gevorkian N, Uhl K. Increasing participation of women in early phase clinical trials approved by the FDA. Womens Health Issues 2009;19:89–93 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources